ArticleCureus2026
A Young Child With Global Developmental Delay and Epilepsy Secondary to a Novel Variant of KBG Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
KBG syndrome is a rare neurodevelopmental disorder caused by changes in the ANKRD11 gene (ankyrin repeat domain-containing protein 11). It is typically inherited in an autosomal dominant pattern. This syndrome is characterized by a distinct constellation of clinical findings, including short stature, distinctive craniofacial manifestations, skeletal abnormalities, and abnormal patterns of hair growth. One of the most important features for diagnosing KBG syndrome is the large size of the upper central incisors, which often facilitates the diagnosis between the ages of seven and eight years after the emergence of the permanent teeth. Other common comorbidities include intellectual impairment, developmental delays (especially in speech), behavioral and emotional problems, seizure disorder, and hearing loss. While the diagnosis is often based on clinical features, whole exome sequencing (WES) remains the gold standard for identification of the underlying genetic abnormality in the ANKRD11 gene. This report presents the clinical findings of a young Bahraini male diagnosed with KBG syndrome to highlight the importance of clinical awareness. By sharing his case, we aim to help healthcare providers to recognize these signs and help these children to get the support they deserve as soon as possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.